Quick Answer
IMMUCELL CORP /DE/ reported Total Revenue of $27.64 million for fiscal year 2025.
IMMUCELL CORP /DE/ Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $27.64M | +4.3% |
| 2024 | $26.49M | +51.6% |
| 2023 | $17.47M | +67.5% |
| 2017 | $10.43M | +9.3% |
| 2016 | $9.54M | -6.7% |
| 2015 | $10.23M | +34.6% |
| 2014 | $7.60M | +26.5% |
| 2013 | $6.01M | +11.5% |
| 2012 | $5.39M | +5.5% |
| 2011 | $5.11M | +16.5% |
| 2010 | $4.39M | -2.7% |
| 2009 | $4.51M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.51M | -8.4% | -14.6% |
| June 30, 2025 | $6.44M | +17.8% | -20.1% |
| March 31, 2025 | $8.07M | +11.2% | +34.2% |
| September 30, 2024 | $6.01M | +11.4% | +9.8% |
| June 30, 2024 | $5.47M | — | -24.6% |
| March 31, 2024 | $7.26M | — | +34.5% |
| September 30, 2023 | $5.40M | — | +87.3% |
| March 31, 2018 | $2.88M | -18.7% | +43.7% |
- IMMUCELL CORP /DE/ showed an increase of +4.3% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, IMMUCELL CORP /DE/’s total revenue has grown by 513.5% (from $4.51 million to $27.64 million).
- The most recent figure is from IMMUCELL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: